Discover what it really takes to design, develop, and validate robust potency assays for CGTs.
Tune in as Daniel Galbraith, Chief Scientific Officer at Solvias, speaks with Greg Russotti, Chief Technology & Manufacturing Officer at Century Therapeutics, and Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics.
Submit form for webinar access.
